161 related articles for article (PubMed ID: 36590218)
1. Decreased circulating branched-chain amino acids are associated with development of Alzheimer's disease in elderly individuals with mild cognitive impairment.
Ikeuchi T; Kanda M; Kitamura H; Morikawa F; Toru S; Nishimura C; Kasuga K; Tokutake T; Takahashi T; Kuroha Y; Miyazawa N; Tanaka S; Utsumi K; Ono K; Yano S; Hamano T; Naruse S; Yajima R; Kawashima N; Kaneko C; Tachibana H; Yano Y; Kato Y; Toue S; Jinzu H; Kitamura A; Yokoyama Y; Kaneko E; Yamakado M; Nagao K
Front Nutr; 2022; 9():1040476. PubMed ID: 36590218
[TBL] [Abstract][Full Text] [Related]
2. The Effects of CSF Neurogranin and
Fan Y; Gao Y; Therriault J; Luo J; Ba M; Zhang H;
Front Aging Neurosci; 2021; 13():667899. PubMed ID: 33986657
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Nutrition-Related Multivariate Biomarker for Mild Cognitive Impairment Based on the Plasma Free Amino Acid Profile.
Ikeuchi T; Yano Y; Sato W; Morikawa F; Toru S; Nishimura C; Miyazawa N; Kuroha Y; Koike R; Tanaka S; Utsumi K; Kasuga K; Tokutake T; Ono K; Yano S; Naruse S; Yajima R; Hamano T; Yokoyama Y; Kitamura A; Kaneko E; Yamakado M; Nagao K
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35276996
[TBL] [Abstract][Full Text] [Related]
4. AD Resemblance Atrophy Index of Brain Magnetic Resonance Imaging in Predicting the Progression of Mild Cognitive Impairment Carrying Apolipoprotein E-ε4 Allele.
Mai Y; Cao Z; Xu J; Yu Q; Yang S; Tang J; Zhao L; Fang W; Luo Y; Lei M; Mok VCT; Shi L; Liao W; Liu J;
Front Aging Neurosci; 2022; 14():859492. PubMed ID: 35572149
[TBL] [Abstract][Full Text] [Related]
5. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
Giannisis A; Al-Grety A; Carlsson H; Patra K; Twohig D; Sando SB; Lauridsen C; Berge G; Grøntvedt GR; Bråthen G; White LR; Kultima K; Nielsen HM
Alzheimers Res Ther; 2022 Aug; 14(1):115. PubMed ID: 36002891
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.
Tervo S; Kivipelto M; Hänninen T; Vanhanen M; Hallikainen M; Mannermaa A; Soininen H
Dement Geriatr Cogn Disord; 2004; 17(3):196-203. PubMed ID: 14739544
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
8. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan.
Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919
[TBL] [Abstract][Full Text] [Related]
9. Disrupted Brain Structural Connectivity: Pathological Interactions Between Genetic APOE ε4 Status and Developed MCI Condition.
Ma C; Wang J; Zhang J; Chen K; Li X; Shu N; Chen Y; Liu Z; Zhang Z
Mol Neurobiol; 2017 Nov; 54(9):6999-7007. PubMed ID: 27785756
[TBL] [Abstract][Full Text] [Related]
10. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
11. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
[TBL] [Abstract][Full Text] [Related]
12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
[TBL] [Abstract][Full Text] [Related]
14. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
15. The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment.
Luo Y; Tan L; Therriault J; Zhang H; Gao Y;
Eur Neurol; 2021; 84(6):472-480. PubMed ID: 34340229
[TBL] [Abstract][Full Text] [Related]
16. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
17. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
Shen S; Zhou W; Chen X; Zhang J;
Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
[TBL] [Abstract][Full Text] [Related]
19. APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease.
Abdullah L; Evans JE; Emmerich T; Crynen G; Shackleton B; Keegan AP; Luis C; Tai L; LaDu MJ; Mullan M; Crawford F; Bachmeier C
Aging (Albany NY); 2017 Mar; 9(3):964-985. PubMed ID: 28333036
[TBL] [Abstract][Full Text] [Related]
20. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
